Schering-Plough to buy Akzo's Organon for $14.5 bln
119312
Akzo Nobel said on Monday it was selling its pharmaceuticals unit Organon BioSciences to Schering-Plough for 11 billion euros ($14.5 billion), dropping plans to float it in a public share offer.
531882
FRANKFURT/ZURICH  - Germany drugmaker Merck KGaA   MRCG.DE unveiled a surprise 16.6-billion-Swiss franc ($13.3   billion) deal on Thursday to buy Swiss biotech firm Serono,   creating a new force in European pharmaceuticals.
590148
Schering-Plough Corp. SGP.N is   seriously considering approaching Bristol-Myers Squibb Co.   BMY.N about a possible merger, according to a report in The   Star-Ledger newspaper on Friday.
108312
Chemical maker Basell said on Tuesday it would buy Lyondell Chemical Co.  for about $12.14 billion, giving it access to Lyondell's commodity assets and refining capacity.
207285
Pfizer Inc. PFE.N has signed a deal  with Schering AG SCHG.DE granting it a worldwide license to  Schering's ADP receptor antagonist program, the U.S. drug maker  said on Wednesday.
703946
Akzo Nobel NV on Friday won EU approval for its $17.1 billion acquisition of Imperial Chemicals Industries PLC, but it must sell off Britain's Crown Paints and an adhesive business to clear antitrust concerns.
40841
Swedish-Dutch chemicals and paints group Akzo Nobel's announced Wednesday that it had completed the purchase of British peer ICI.
713941
GlaxoSmithKline Plc  has bought global rights to Danish biotech company Genmab's  most promising new drug, a treatment for leukemia, in a record deal worth up to $2.1 billion, the two firms said on Tuesday.
541389
BOSTON, Aug. 29 -- Schering-Plough Corp. on Tuesday agreed to pay $435 million and plead guilty to conspiracy to settle a federal investigation into marketing of its drugs for unapproved uses and overcharging Medicaid for certain drugs.
356950
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck unveiled a   $13.3-billion deal to buy Europe's top biotech firm Serono, and   Denmark's Nycomed won the drugs unit of Altana.
518270
AMSTERDAM -- Schering-Plough Corp. agreed to buy Akzo Nobel NV's drug-making division Organon for $14.4 billion to gain the world's third-largest maker of birth-control pills and a stable of experimental medicines.
639985
As part of its push to become a bigger player in cancer drugs, Genzyme Corp. of Cambridge said yesterday it will buy out business partner Bioenvision Inc. of New York for $345 million , consolidating its ownership of a cancer treatment to which the two companies had been sharing rights.
423754
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck MRCG.DE   unveiled a $13.3-billion deal to buy Europe's top biotech firm   Serono SEO.VX, and Denmark's Nycomed won the drugs unit of   Altana ALTG.DE.
346203
Swedish-Dutch chemicals and paints group Akzo Nobel's announced Wednesday that it had completed the purchase of peer ICI.
174390
Gallaher Group, the maker of the Benson & Hedges brand in Europe, said it had received an offer of Â£7.5 billion ($14.7 billion).
694949
Belgian drugmaker UCB UCBBt.BR has   agreed to buy Germany's Schwarz Pharma SRZG.DE for around   $5.6 billion in shares and cash, in the third major drug sector   transaction in Germany in five days.
150005
Swiss biotech firm Serono SA, which earlier Thursday agreed to sell a majority stake in the company to German drugmaker Merck KGaA for $13.31 billion, said its oral cladribine treatment for multiple sclerosis has received "fast-track" status from the U.S. Food and Drug Administration.